Astragalus Membranaceus Treatment Protects Raw264.7 Cells from Influenza Virus by Regulating G1 Phase and the TLR3-Mediated Signaling Pathway

Figure 3

Effect of AMI on the cell cycle of Raw264.7 cells infected with influenza virus. (a) Normal control group. (b) AMI group (9.5 mg/ml). (c) Virus + AMI (40 mg/ml). (d) Virus + AMI (92 mg/ml). (e) Virus control group. (f) Virus + AMI (9.5 mg/ml). (g) AMI group (40 mg/ml). (h) AMI group (92 mg/ml).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)